Human CTRP4 gene, its coding protein and their application

A protein and gene technology, applied in the fields of peptide/protein composition, application, gene therapy, etc.

Active Publication Date: 2012-02-01
PEKING UNIV
View PDF3 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Second, compared with other members of CT...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human CTRP4 gene, its coding protein and their application
  • Human CTRP4 gene, its coding protein and their application
  • Human CTRP4 gene, its coding protein and their application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] Example 1: Cloning and identification of human new secreted protein CTRP4

[0056] The inventors searched THMHMM and SignalP databases using bioinformatics methods, and found that the existing published CTRP4 protein does not have a typical transmembrane domain but contains a potential N-terminal signal peptide. This analysis strongly supports that the currently published CTRP4 may be a new potential secreted protein. In order to further confirm the currently published secreted form of CTRP4 and its signal peptide cleavage site, we performed N-terminal sequencing of CTRP4 secreted protein to verify the exact sequence of its secreted and mature CTRP4. The sequencing results clearly show that CTRP4 is a new secreted protein (SEQ ID NO.: 2), and its actual signal peptide cleavage site is located between the 16th and 17th amino acids of the existing published CTRP4 protein, which is consistent with biological information The predicted sites are consistent.

[0057] In ord...

Embodiment 2

[0058] Example 2: Overexpression of CTRP4 protein can effectively induce the activation of IL6-STAT3 and NF-KB signaling pathways

[0059] First of all, we studied the biological activity of CTRP4 gene and protein through RT-PCR test and PCR technique. As described in Example 1, the pcDNA3.1-CTRP4-myc fusion plasmid was overexpressed in human liver cancer cell HepG2 (commercially purchased), and the test results showed that in the HepG2 cell line overexpressing the CTRP4 gene, the mRNA level of IL6 was overexpressed Significant dose-dependent upregulation. ( figure 2 ).

[0060]Existing studies have shown that there is a very complex positive feedback loop between IL6-STAT3 and NF-κB interaction network, which plays a decisive role in the molecular regulation of tumorigenesis and tumor transformation. Given the close association of CTRP4 to the IL6-STAT3 signaling pathway, we further investigated the relationship between CTRP4 and NF-κB activation.

[0061] We detected th...

Embodiment 3

[0063] Therefore, the CTRP4 gene antagonist can be applied to the preparation of drugs for inhibiting the activity of NF-κB and / or IL6-STAT3 pathway. The antagonist is an siRNA molecule or an antisense RNA that blocks or blocks the mRNA transcribed by the CTRP4 gene. Techniques of how to block or block gene expression using antagonists are known in the art. Example 3: Biological activity of secreted protein CTRP4 (SEQ ID NO.2)

[0064] The above results show that CTRP4 is a new secreted protein, and overexpression of CTRP4 in some cancer cell lines can induce the activation of IL6-STAT3 pathway. Accordingly, we hypothesized that the secreted protein CTRP4 may be involved in the regulation of tumor-associated inflammation as a potential secreted regulatory factor.

[0065] First, we tested whether the culture supernatant of HepG2 cells overexpressing CTRP4 had similar biological functions as we expected to overexpress CTRP4. We transferred the overexpression supernatant to H...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a kind of human gene CTRP4 and its coding CTRP4 protein. The invention also relates to the application of an antagonist of the gene and protein in the preparation of NF-kappaB and/or IL6-STAT3 pathway activity inhibiting drug, and relates to the application of an agonist of the gene and the protein in the preparation of hematopoiesis promoting drug and GP130 molecule up-regulating drug.

Description

technical field [0001] The present invention relates to a new human gene CTRP4 and its encoded CTRP4 protein, and the present invention also relates to the application of an antagonist of the gene and protein in the preparation of drugs for inhibiting the activity of NF-κB and / or IL6-STAT3 pathways , the agonist of the gene and the application of the protein in the preparation of drugs for promoting hematopoiesis and in the preparation of drugs for up-regulating GP 130 molecules. Background technique [0002] Current research has known that normal cells maintain their physiological functions and phenotypes need to balance the two physiological processes of autoimmune response and anti-inflammatory response, and a strict monitoring mechanism is required to maintain this balance. Inflammatory response that is too long and too strong will directly lead to the occurrence and development of tumors. In addition, the inflammatory response is also a necessary process for distant me...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/12C07K14/47A61K48/00A61K45/00A61K39/395A61K38/17A61P7/06A61P29/00A61P35/00A61P43/00
Inventor 王露李琦马大龙王兰兰谭伟峰
Owner PEKING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap